Search Results - "Juliana Lott Carvalho"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia by Oliveira, Paula M., Alencar-Silva, Thuany, Pires, Felipe Q., Cunha-Filho, Marcilio, Gratieri, Tais, Carvalho, Juliana Lott, Gelfuso, Guilherme M.

    “…[Display omitted] •Minoxidil and latanoprost are compatible, which enabled their association.•The drugs combination’s bioactivity was encouraging, especially…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression by de Oliveira Bravo, Martha, Carvalho, Juliana Lott, Saldanha-Araujo, Felipe

    Published in Purinergic signalling (01-12-2016)
    “…Adenosine is an important molecule that exerts control on the immune system, by signaling through receptors lying on the surface of immune cells. This…”
    Get full text
    Journal Article
  7. 7

    Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment by Saldanha-Araujo, Felipe, Melgaço Garcez, Emãnuella, Silva-Carvalho, Amandda Evelin, Carvalho, Juliana Lott

    Published in Frontiers in immunology (03-07-2020)
    “…COVID-19 is a disease characterized by a strong inflammatory response in severe cases, which fails to respond to corticosteroid therapy. In the context of the…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Immunomodulatory effect of IFN-γ licensed adipose-mesenchymal stromal cells in an in vitro model of inflammation generated by SARS-CoV-2 antigens by Bispo, Elizabete Cristina Iseke, Argañaraz, Enrique Roberto, Neves, Franscisco de Assis Rocha, de Carvalho, Juliana Lott, Saldanha-Araujo, Felipe

    Published in Scientific reports (16-10-2024)
    “…In recent years, clinical studies have shown positive results of the application of Mesenchymal Stromal Cells (MSCs) in severe cases of COVID-19. However, the…”
    Get full text
    Journal Article
  13. 13

    Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis by de Carvalho, Bruna Caroline, Vital, Tamires, Osiro, Jaqueline, Gomes, Ciro Martins, Noronha, Elza, Dallago, Bruno, Rosa, Ana de Cássia, Carvalho, Juliana Lott, Hagström, Luciana, Hecht, Mariana, Nitz, Nadjar

    “…Tegumentary leishmaniasis is a tropical disease caused by protozoa of the genus Leishmania. Clinically, the disease presents a broad spectrum of symptoms, the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Ibrutinib Modulates Proliferation, Migration, Mitochondrial Homeostasis, and Apoptosis in Melanoma Cells by Lins, Fernanda Vitelli, Bispo, Elizabete Cristina Iseke, Rodrigues, Naomí Souza, Silva, Maria Victória Souto, Carvalho, Juliana Lott, Gelfuso, Guilherme Martins, Saldanha-Araujo, Felipe

    Published in Biomedicines (01-05-2024)
    “…Ibrutinib, a tyrosine kinase inhibitor with a broad spectrum of action, has been successfully explored to treat hematological and solid cancers. Herein, we…”
    Get full text
    Journal Article
  17. 17

    Development and Validation of a Chromatographic Method for Ibrutinib Determination in Human and Porcine Skin by Albuquerque, Lucas F. F., Souto, Maria Victoria, Saldanha-Araujo, Felipe, Carvalho, Juliana Lott, Gratieri, Tais, Cunha-Filho, Marcilio, Gelfuso, Guilherme M.

    Published in Chemistry an international journal (01-04-2024)
    “…Ibrutinib (IBR) is a tyrosine kinase inhibitor investigated for treating solid and non-solid tumors. Considering the advantages that a topical application of…”
    Get full text
    Journal Article
  18. 18

    Molecular and functional anticancer effects of GLP/G9a inhibition by UNC0646 in MeWo melanoma cells by Filiú-Braga, Luma Dayane de Carvalho, Silva-Carvalho, Amanda Évelin, Sousa, Marielly Reis Resende, Carvalho, Juliana Lott, Saldanha-Araujo, Felipe

    Published in Heliyon (15-03-2024)
    “…In recent years, histone methyltransferases (HMTs) have emerged as important therapeutic targets in cancer due to their oncogenic role. Herein, we used the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells by Oliveira, Maira Souza, Carvalho, Juliana Lott, Campos, Ana Carolina De Angelis, Gomes, Dawidson Assis, de Goes, Alfredo Miranda, Melo, Marília Martins

    Published in Toxicology letters (30-01-2014)
    “…•Mesenchymal stem cells (MSCs) were isolated from rats that received doxorubicin.•Doxorubicin had toxic effects on MSCs.•MSCs grew up in lower rates and had…”
    Get full text
    Journal Article